Literature DB >> 32539096

Error in Figure.

.   

Abstract

Entities:  

Year:  2020        PMID： 32539096      PMCID： PMC7296448          DOI： 10.1001/jamaneurol.2020.2025

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  1 in total

1.  Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial.

Authors:  Paula R Clemens; Vamshi K Rao; Anne M Connolly; Amy D Harper; Jean K Mah; Edward C Smith; Craig M McDonald; Craig M Zaidman; Lauren P Morgenroth; Hironori Osaki; Youhei Satou; Taishi Yamashita; Eric P Hoffman
Journal:  JAMA Neurol       Date:  2020-08-01       Impact factor: 18.302
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.